Excitement is palpable among Vapi’s traders as the India-EU Free Trade Agreement takes center stage, offering a strategic pivot from the punishing US tariffs that have plagued exports. Gujarat’s industrial powerhouse, home to thousands of SMEs in diverse sectors, views this as a game-changer.

With chemicals, pharma, textiles, and engineering thriving here, the region’s 10,000-plus units have been hit hard by American protectionism. Now, the EU deal paves the way for new markets, enabling businesses to diversify and recover lost ground.

In an exclusive interview, Dr. Kamal Wasi of Mangalam Drugs revealed how the FTA eliminates barriers for Indian generics in Europe. ‘Our industry, reeling from US tariffs, now sees a positive shift with open access to all EU nations,’ he stated, forecasting rapid business expansion.

Industry leader Shard Thakar described the agreement as unprecedented under PM Modi’s stewardship. ‘It addresses the damages from Trump-era tariffs by unlocking stable European partnerships, ensuring long-term industry resilience,’ he emphasized.

Vapi Industries Association chief Satish Patel went further, labeling it a pivotal ‘mother of all deals’ for multiple sectors. ‘Direct trade with Europe will heal wounds from US losses and accelerate industrial progress toward Viksit Bharat,’ Patel said.

Beyond exports, the pact promises cheaper imports, boosting competitiveness. Analysts predict a ripple effect: heightened investments, skill development, and Vapi’s emergence as an export gateway to Europe, revitalizing the local economy.